Abstract
Epileptic seizures are common symptoms in patients with glioma, occurring at disease presentation as well as during later disease. The frequency of tumor-related seizures is strongly related to the growth rate of the tumor. In low-grade gliomas, seizures as initial symptom leading to the brain tumor diagnosis occur in 70–90% of all patients. About 50% of these patients continue to have seizures before operation in spite of optimal antiepileptic drug treatment. In high-grade gliomas, seizures at disease presentation are less frequent and occur in only 30–50% of all patients but may be more difficult to control. Apart from the tumor growth rate, the specific location of the tumor in the brain and its proximity to the cortex affect seizure risk and seizure control in glioma. For many patients with tumor-related seizures, optimal seizure control is not achieved by antiepileptic drugs only but requires additional therapy such as surgical resection and/or radio- and chemotherapy. In this review, we discuss different aspects of the clinical presentation of the disease in patients with tumor-related seizures. We also discuss the possible therapeutic strategies for patients with medically refractory seizures, illustrating the importance of a qualified specialized team of neuro-oncologists, neurologists and neurosurgeons for the optimal management of this patient group.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aronica E, Gorter JA, van Vliet EA, Spliet WG, van Veelen CW, van Rijen PC, Leenstra S, Ramkema MD, Scheffer GL, Scheper RJ, Sisodiya SM, Troost D (2003) Overexpression of the human major vault protein in gangliogliomas. Epilepsia 44:1166–1174
Beaumont A, Whittle IR (2000) The pathogenesis of tumour associated epilepsy. Acta Neurochir (Wien) 142:1–15
Berntsson SG, Malmer B, Bondy ML, Qu MQ, Smits A (2009) Tumor-associated epilepsy and glioma; Are there common genetic pathways? Acta Oncol 48:328–342
Brada M, Viviers L, Abson C, Hines F, Britton J, Ashley S, Sardell S, Traish D, Gonsalves A, Wilkins P, Westbury C (2003) Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol 14:1715–1721
Brogna C, Gil Robles S, Duffau H (2008) Brain tumors and epilepsy. Exper Rev Neurother 8:941–955
Cavaliere R, Farace E, Schiff D (2006) Clinical implications of status epilepticus in patients with neoplasms. Arch Neurol 63:1746–1749
Chaichana KL, Parker SL, Olivi A, Quiñones-Hinojosa A (2009) Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas. J Neurosurg 111:282–292
Chang EF, Potts MB, Keles GE, Lamborn KR, Chang SM, Barbaro NM, Berger MS (2008) Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg 108:227–235
Cibula JE, Gilmore RL (1997) Secondary epileptogenesis in humans. J Clin Neurophys 14:111–127
Devinsky O (1999) Patients with refractory seizures. N Eng J Med 340:1565–1570
Duffau H (2009) Surgery of low-grade gliomas: towards a ‘functional neurooncology’. Curr Opin Oncol 21:543–549
Duffau H, Capelle L (2004) Preferential brain locations of low-grade gliomas. Cancer 100:2622–2626
Glantz MJ, Cole BF, Forsyth PA, Recht LD, Wen PY, Chamberlain MC, Grossman SA, Cairncross JG (2000) Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 54:1886–1893
Hildebrand J, Lecaille C, Perennes J, Delattre JY (2005) Epileptic seizures during follow-up of patients treated for primary brain tumors. Neurology 65:212–215
Kalachikov S, Evgrafov O, Ross B, Winawer M, Barker-Cummings C, Martinelli Boneschi F, Choi C, Morozov P, Das K, Teplitskaya E, Yu A, Cayanis E, Penchaszadeh G, Kottmann AH, Pedley TA, Hauser WA, Ottman R, Gilliam TC (2002) Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet 30:335–341
King MA, Newton MR, Jackson GD, Fitt GJ, Mitchell LA, Silvapulle MJ, Berkovic SF (1998) Epileptology of the first-seizure presentation: a clinical, electroencephalographic, and magnetic resonance imaging study of 300 consecutive patients. Lancet 352:1007–1011
Klein M, Engelberts NH, van der Ploeg HM, Kasteleijn-Nolst Trenité DG, Aaronson NK, Taphoorn MJ, Baaijen H, Vandertop WP, Muller M, Postma TJ, Heimans JJ (2003) Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol 54:514–520
Lombardi D, Marsh R, de Tribolet N (1997) Low grade glioma in intractable epilepsy: lesionectomy versus epilepsy surgery. Acta Neurochir 68(Suppl):70–74
Lowenstein DH, Alldredge BK (1993) Status epilepticus at an urban public hospital in the 19802. Neurology 3:483–488
Manford M, Fish DR, Shorvon SD (1996) An analysis of clinical seizure patterns and their localizing value in frontal and temporal lobe epilepsies. Brain 119:17–40
Olafsson E, Ludvigsson P, Gudmundsson G, Hesdorffer D, Kjartansson O, Hauser WA (2005) Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: a prospective study. Lancet Neurol 4:627–634
Pace A, Vidiri A, Galiè E, Carosi M, Telera S, Cianciulli AM, Canalini P, Giannarelli D, Jandolo B, Carapella CM (2003) Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response. Ann Oncol 14:1722–1726
Schaller B, Rüegg SJ (2003) Brain tumor and seizures: pathophysiology and its implications for treatment revisited. Epilepsia 44:1223–1232
Taillandier L, Duffau H (2009) Epilepsy and insular Grade II gliomas: an interdisciplinary point of view from a retrospective monocentric series of 46 cases. Neurosurg Focus 27:E8
Taphoorn MJ, Klein M (2004) Cognitive deficits in adult patients with brain tumours. Lancet Neurol 3:159–168
van Breemen MS, Wilms EB, Vecht CJ (2007) Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol 6:421–430
van den Bent MJ, Afra D, de Witte O, Ben Hassel M, Schraub S, Hoang-Xuan K, Malmström PO, Collette L, Piérart M, Mirimanoff R, Karim AB, EORTC Radiotherapy and Brain Tumor Groups and the UK Medical Research Council (2005) Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 366:985–990
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Smits, A., Storstein, A. (2011). Tumor-Associated Epilepsy in Patients with Glioma. In: Hayat, M. (eds) Tumors of the Central Nervous System, Volume 2. Tumors of the Central Nervous System, vol 2. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-0618-7_39
Download citation
DOI: https://doi.org/10.1007/978-94-007-0618-7_39
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-0617-0
Online ISBN: 978-94-007-0618-7
eBook Packages: MedicineMedicine (R0)